OtherArticle
Inhibition of c-Myc down-regulation by sustained ERK activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small cell lung cancer cells
Jordi M Serra, Antonio Gutierrez, Regina Alemany, Maria Navarro, Teresa Ros, Carlos Saus, Jordi Gines, Antonia Sampol, Juan Carlos Amat, Lorenzo Serra-Moises, Javier Martin, Antonio Galmes, Oliver Vogler and Joan Besalduch
Molecular Pharmacology March 19, 2008, DOI: https://doi.org/10.1124/mol.107.043372
Jordi M Serra
Antonio Gutierrez
Regina Alemany
Maria Navarro
Teresa Ros
Carlos Saus
Jordi Gines
Antonia Sampol
Juan Carlos Amat
Lorenzo Serra-Moises
Javier Martin
Antonio Galmes
Oliver Vogler
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
Inhibition of c-Myc down-regulation by sustained ERK activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small cell lung cancer cells
Jordi M Serra, Antonio Gutierrez, Regina Alemany, Maria Navarro, Teresa Ros, Carlos Saus, Jordi Gines, Antonia Sampol, Juan Carlos Amat, Lorenzo Serra-Moises, Javier Martin, Antonio Galmes, Oliver Vogler and Joan Besalduch
Molecular Pharmacology March 19, 2008, DOI: https://doi.org/10.1124/mol.107.043372
OtherArticle
Inhibition of c-Myc down-regulation by sustained ERK activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small cell lung cancer cells
Jordi M Serra, Antonio Gutierrez, Regina Alemany, Maria Navarro, Teresa Ros, Carlos Saus, Jordi Gines, Antonia Sampol, Juan Carlos Amat, Lorenzo Serra-Moises, Javier Martin, Antonio Galmes, Oliver Vogler and Joan Besalduch
Molecular Pharmacology March 19, 2008, DOI: https://doi.org/10.1124/mol.107.043372
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement